Around an aesthetic procedure, do not use a universal online number of days to stop or restart retinol, AHA, or BHA. First disclose the exact product, application area, planned procedure, and current skin-barrier condition. Cellinique explains that decisions about pausing or restarting active ingredients should consider the procedure, skin barrier, and whether the product is prescribed, not the ingredient name alone. Bring a label or prescription record to the consultation.
Why one “active ingredient” category is not enough
The name retinol, AHA, or BHA does not show the formulation, frequency, application area, or combination with other ingredients. Burning, redness, peeling, dryness, and a recent product change are useful consultation details.
Procedures also differ in area and surface impact. An online schedule cannot replace individual instructions. Use skincare routine order guidance for everyday sequencing, but prioritize procedure-specific advice.
During consultation, first distinguish a cosmetic from a prescribed product, whole-face from limited-area use, and routine tolerance from recent irritation. Then compare that information with the planned treatment area and instructions already given. This turns “must I always stop retinol?” into a question about the product, skin, and procedure.
Record the ingredient and skin response before consultation
Prepare a label photo, application area, frequency, last use, and recent irritation. Product form alone does not identify its ingredients.
Report warmth, redness, peeling, itch, rash, and when each began. The record supports planning; it does not diagnose the cause online.
For example, if a familiar product has recently irritated only one area, describe both the area and the order of changes rather than its name alone. Likewise, disclose a new product even when no reaction has appeared. A complete account helps the clinician decide what needs further review.
Read AHA material as sun-safety information
FDA AHA cosmetic-label guidance notes that topical AHA may increase skin sensitivity to sunlight during use and for a period after use is stopped, and recommends sunscreen, protective clothing, and limiting exposure. It does not set a stop-day rule around aesthetic procedures.
FDA also notes that some medicines and topical products can contribute to photosensitivity. Plan shade, clothing, and sun protection with the skin condition and procedure instructions, and disclose sun exposure plans.
Keep prescribed products separate from self-directed changes
Do not treat prescribed retinoids or other prescribed skin treatments like cosmetics. Do not independently stop, restart, change frequency, or change dose; disclose the product and regimen to both the prescriber and treating clinician.
Do not use a “gentle” cosmetic claim to choose a restart date. If instructions are unclear, ask about the product and area, and keep notes with the aftercare checklist.
Confirm restart through response and instructions, not a calendar
Restart timing can vary with the procedure, surface condition, ongoing burning, redness, peeling, and prescription status. There is no universal number of days. Do not test several products together when irritation remains or a new reaction appears.
When receiving restart instructions, confirm which product goes on which area, whether more than one item will change at once, and whom to contact if irritation remains. Sharing the current response and last use—not only asking whether you may restart—helps avoid misunderstanding the scope of the advice.
Rapidly worsening pain, warmth, swelling, blisters, drainage, or spreading rash should not be assumed to be a product reaction. See treatment safety information and contact the treating clinic. This is general information; individual diagnosis and treatment decisions require consultation.
Checklist before discussing active ingredients and a procedure
- Bring a product label or full-ingredient photo.
- Record area, frequency, last use, and recent irritation.
- Disclose whether it is prescribed and the prescriber.
- Do not apply a fixed stop or restart date yourself.
- Share sun-exposure plans and current skin status.
- Report worsening pain, warmth, blisters, drainage, or rash.
Frequently asked questions
Q1. How many days before a procedure should I stop retinol?
No single period fits everyone. Tell the clinician whether it is prescribed, the procedure, and your skin response, then obtain individual instructions.
Q2. Are AHA and BHA adjusted the same way?
Do not decide from the names alone. Show the label, area and frequency of use, and current irritation.
Q3. Does AHA require extra sun caution?
FDA notes possible increased sun sensitivity with AHA cosmetics. Plan limited exposure, clothing, shade, and sunscreen together.
Q4. Can I pause a prescribed retinoid myself?
No. Do not independently stop, restart, or alter prescribed treatment; ask the prescriber and treating clinician.
Q5. Can I add several soothing products if my skin stings after a procedure?
Adding several products makes causes harder to distinguish. Contact the clinic for persistent or worsening irritation.
This article provides general information. An individual diagnosis or treatment plan requires a consultation.
